BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 12004667)

  • 21. Oral and maxillofacial pathology case of the month. Verrucous carcinoma.
    Jones AC; McGuff HS
    Tex Dent J; 2008 Jul; 125(7):622-3, 627. PubMed ID: 18717430
    [No Abstract]   [Full Text] [Related]  

  • 22. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases.
    Bagan JV; Jiménez-Soriano Y; Diaz-Fernandez JM; Murillo-Cortés J; Sanchis-Bielsa JM; Poveda-Roda R; Bagan L
    Oral Oncol; 2011 Aug; 47(8):732-5. PubMed ID: 21683646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia.
    Gouvêa AF; Vargas PA; Coletta RD; Jorge J; Lopes MA
    J Oral Pathol Med; 2010 Jul; 39(6):447-52. PubMed ID: 20412398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferative verrucous leukoplakia: a report of ten cases.
    Zakrzewska JM; Lopes V; Speight P; Hopper C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Oct; 82(4):396-401. PubMed ID: 8899776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of relationship between risk factors of malignant transformation of oral leukoplakia and the LSCP system].
    Sun Z; Gong Y; Huang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):364-6. PubMed ID: 11769652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma.
    Bagan JV; Jimenez Y; Sanchis JM; Poveda R; Milian MA; Murillo J; Scully C
    J Oral Pathol Med; 2003 Aug; 32(7):379-82. PubMed ID: 12846783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited proliferative oral disorder: a reductionist approach to proliferative verrucous leukoplakia.
    Radhakrishnan R
    Indian J Dent Res; 2011; 22(3):365-6. PubMed ID: 22048571
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid progression of an idiopathic leukoplakia to a proliferative verrucous leukoplakia lesion and then squamous cell carcinoma.
    Dal Vechio A; Nakagima E; Azevedo LH; Alves FA; Migliari DA
    Quintessence Int; 2012; 43(7):583-5. PubMed ID: 22670253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature.
    Cabay RJ; Morton TH; Epstein JB
    J Oral Pathol Med; 2007 May; 36(5):255-61. PubMed ID: 17448134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferative verrucous leukoplakia: an aggressive form of oral leukoplakia.
    Shopper TP; Brannon RB; Stalker WH
    J Dent Hyg; 2004; 78(3):7. PubMed ID: 16197744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
    Schepman KP; van der Meij EH; Smeele LE; van der Waal I
    Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal studies in oral leukoplakias.
    Bánóczy J; Sugár L
    J Oral Pathol; 1972; 1(6):265-72. PubMed ID: 4217821
    [No Abstract]   [Full Text] [Related]  

  • 33. Proliferative verrucous leukoplakia: unusual locations of oral squamous cell carcinomas, and field cancerization as shown by the appearance of multiple OSCCs.
    Bagán JV; Murillo J; Poveda R; Gavaldá C; Jiménez Y; Scully C
    Oral Oncol; 2004 Apr; 40(4):440-3. PubMed ID: 14969824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High incidence of DNA ploidy abnormalities and increased Mcm2 expression may predict malignant change in oral proliferative verrucous leukoplakia.
    Gouvêa AF; Santos Silva AR; Speight PM; Hunter K; Carlos R; Vargas PA; de Almeida OP; Lopes MA
    Histopathology; 2013 Mar; 62(4):551-62. PubMed ID: 23347057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Proliferative verrucous leukoplakia].
    Lindenmüller IH; Lambrecht JT
    Schweiz Monatsschr Zahnmed; 2006; 116(5):508-20. PubMed ID: 16792055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukoplakia: still a gallimaufry or is progress being made?--A review.
    Suarez P; Batsakis JG; el-Naggar AK
    Adv Anat Pathol; 1998 May; 5(3):137-55. PubMed ID: 9868520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical manifestations of oral proliferative verrucous leukoplakia: A systematic review.
    Torrejon-Moya A; Jané-Salas E; López-López J
    J Oral Pathol Med; 2020 May; 49(5):404-408. PubMed ID: 31990082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative verrucous leukoplakia: a case report of multiple metachronous oral verrucous carcinoma.
    Lombardi N; Varoni EM; Franchini R; Lodi G
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral proliferative verrucous leukoplakia (PVL); open trial of surgery compared with combined therapy using surgery and methisoprinol in papillomavirus-related PVL.
    Femiano F; Gombos F; Scully C
    Int J Oral Maxillofac Surg; 2001 Aug; 30(4):318-22. PubMed ID: 11518355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentially malignant disorders revisited-The lichenoid lesion/proliferative verrucous leukoplakia conundrum.
    Thomson PJ; Goodson ML; Smith DR
    J Oral Pathol Med; 2018 Jul; 47(6):557-565. PubMed ID: 29663518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.